XTX Topco’s Silo Pharma SILO Stock Holding History

XTX Topco’s Portfolio SILO Stock Details SILO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-1,139	Closed	-$6.14K	–	4656
2026 Q1	$6.14K	Sell	1,139 -2,654	-70%	-$13.7K	﹤0.01%	3744
2025 Q4	$19.3K	Buy	+3,793	New	+$28K	﹤0.01%	3066
2025 Q3	–	Sell	-1,788	Closed	-$16.9K	–	3204
2025 Q2	$16.9K	Buy	+1,788	New	+$20.5K	﹤0.01%	2190
2025 Q1	–	Sell	-971	Closed	-$13K	–	3029
2024 Q4	$13K	Buy	+971	New	+$15K	﹤0.01%	2113

Other funds holding SILO

AdvisorShares Investments Bethesda, Maryland $828M AUM 37.72% 1-Year Est. Return

FIA

FNY Investment Advisers New York $278M AUM 98.95% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

TRCT

Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return

Harbour Investments Madison, Wisconsin $7.43B AUM 24.49% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

XTX Topco's SILO Position: Q2 2026 in Review

XTX Topco sold out of Silo Pharma (SILO) in Q2 2026, closing a stake of 1,139 shares — an estimated $6.14K sold.

XTX Topco first reported a position in SILO in Q4 2024 and held it in 4 quarters. The position peaked at $19.3K in Q4 2025. 9 funds tracked by Wall St. Rank hold SILO as of Q2 2026.

XTX Topco reported no remaining Silo Pharma position as of Q2 2026 after selling out during the quarter.
XTX Topco sold 1,139 Silo Pharma shares in Q2 2026, an estimated $6.14K.
XTX Topco first reported a position in Silo Pharma in Q4 2024 and held it in 4 quarters.
XTX Topco's Silo Pharma position peaked at $19.3K in Q4 2025.
9 funds tracked by Wall St. Rank held Silo Pharma as of Q2 2026.

Based on XTX Topco's 13F filing for Q2 2026, filed 14 Aug 2026.